Status:
RECRUITING
Contribution of Per Dialytic Physical Activity in Chronic Dialysis Patients
Lead Sponsor:
Centre Hospitalier Intercommunal André Grégoire
Conditions:
Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dialysis patients have reduced walking capacity and an important risk of high blood pressure. These complications are associated with a decline in quality of life and increased mortality. The hypothes...
Detailed Description
Dialysis patients have reduced aerobic capacity, walking ability, and an increased risk of hypertension. These complications are associated with a decline in quality of life and increased mortality. ...
Eligibility Criteria
Inclusion Criteria:
- Adults aged 18 and over, undergoing chronic hemodialysis at CHI André Grégoire for more than 3 months.
- Consent to participate in physical activity during dialysis sessions.
- Written informed consent.
- Affiliation with a social security system
Exclusion Criteria:
- Lower limb amputation without a prosthesis.
- Non-healed foot wounds.
- Hemoglobin < 8 g/dl.
- Patient refusal to participate.
- Severe respiratory (oxygen dependence) or cardiac disease (NYHA class 3 or 4, LVEF < 30%).
- Advanced dementia or psychiatric illness impeding cooperation, or refusal to consent.
- Non-French speaking patients unable to understand the study.
- Patients under guardianship.
- Advanced osteoarthritis, recent hip or knee prosthesis (< 3 months).
- Hypotension (BP < 90/40 mmHg) or hypertension (BP > 180/110 mmHg).
- Fever (temperature >= 38°C).
- Hypoglycemia (fingerstick glucose < 0.8 g/l) in diabetic patients.
- Dyspnea or desaturation in ambient air < 95%.
- COVID-19 symptoms within the last 21 days, positive PCR test, unable to pedal.
- Chest pain or unstable angina.
- Muscle or joint contraindications to the pedal exerciser as assessed by a physiotherapist
Key Trial Info
Start Date :
March 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06471283
Start Date
March 14 2024
End Date
March 31 2025
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Andre Gergoire
Montreuil, France, 93100